ATLANTA, Oct. 10 (UPI) -- One in four teenage girls received at least one dose of a relatively new vaccine against cervical cancer, U.S. health officials said.
CANBERRA, Australia, Nov. 29 (UPI) -- Australian Prime Minister John Howard has announced a $342 million cervical cancer vaccination program.
WHITEHOUSE STATION, N.J., Nov. 1 (UPI) -- Merck said Wednesday the U.S. Centers for Disease Control and Prevention added Gardasil to its Vaccines for Children program.
WHITEHOUSE STATION, N.J., Sept. 22 (UPI) -- Merck said Friday the European Commission approved its cervical cancer vaccine Gardasil for use in children and adults.
PHOENIX, Aug. 1 (UPI) -- Blue Cross Blue Shield of Arizona (BCBSAZ) said Tuesday it would cover Merck's recently approved cervical cancer vaccine Gardisil.
WHITE HOUSE STATION, N.J., Feb. 7 (UPI) -- Merck said Tuesday its cervical cancer vaccine Gardasil has been granted priority review.
BIRMINGHAM, England, Dec. 4 (UPI) -- New research into the body's immune response to the human papilloma virus (HPV) could lead to a vaccine against cervical cancer, a study said.
WHITEHOUSE STATION, N.J., Oct. 6 (UPI) -- An investigational vaccine made by New Jersey-based, Merck & Co. has been found 100 percent effective in preventing cervical cancers.
NEW YORK, April 7 (UPI) -- A new experimental vaccine can reduce the risk of cervical cancer by 90 percent, a study says.
LONDON, Oct. 29 (UPI) -- British researchers say a vaccine against cervical cancer could be available within three years, the BBC reported Friday.
